Brief: BORYUNG PHARM signs 85.42 bln won contract with SANDOZ AG
June 20 (Reuters) - BORYUNG PHARM CO.,LTD 003850.KS :
* Says it signs contract with SANDOZ AG, to obtain
exclusivity license in South Asia and to supply medicines
* Says contract price is 85.42 billion won
Source text in Korean: http://me2.do/FHbi4Vhz
Further company coverage: 003850.KS
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: lusha.zhang.reuters.com@reuters.net))
Recent news on Boryung
See all newsBrief: Boryung Corp Q1 Operating Profit 20.2 Billion Won, Up 84.7% From Year Earlier
Brief: Boryung Corp Q4 Operating Profit 20 Billion Won, Up 36% From Year Earlier
Brief: Boryung Corp Q2 Operating Profit 25.4 Billion Won, Up 26% From Year Earlier
Brief: Boryung Q1 Operating Profit 11 Billion Won, Down 33% From Year Earlier
Brief: Boryung Corp Q4 Operating Profit 14.6 Billion Won, Down 1.5% From Year Earlier